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Background. Fish oil supplementation has been shown
to alter gene expression ofmononuclear cells both in
vitro and in vivo. However, little is known about the
total transcriptome profile in healthy subjects after
intake of fish oil. We therefore investigated the gene
expression profile in peripheral blood mononuclear
cells (PBMCs) after intake of fish oil for 7 weeks
using transcriptome analyses.
Design. In a 7-week, double-blinded, randomized, con-
trolled, parallel-group study, healthy subjects
received 8 g day1 fish oil (1.6 g day1 eicosapenta-
enoic acid + docosahexaenoic acid) (n = 17) or
8 g day1higholeic sunfloweroil (n = 19).Microarray
analyses of RNA isolated fromPBMCswere performed
at baseline and after 7 weeks of intervention.
Results. Cell cycle, DNA packaging and chromosome
organization are biological processes found to be
upregulated after intake of fish oil compared to
high oleic sunflower oil using a moderated t-test.
In addition, gene set enrichment analysis identi-
fied several enriched gene sets after intake of fish
oil. The genes contributing to the significantly
different gene sets in the subjects given fish oil
compared with the control group are involved in
cell cycle, endoplasmic reticulum (ER) stress and
apoptosis. Gene transcripts with common motifs
for 35 known transcription factors including E2F,
TP53 and ATF4 were upregulated after intake of
fish oil.
Conclusion. We have shown that intake of fish oil for
7 weeks modulates gene expression in PBMCs of
healthy subjects. The increased expression of
genes related to cell cycle, ER stress and apoptosis
suggests that intake of fish oil may modulate basic
cellular processes involved in normal cellular func-
tion.
Keywords: fish oil, intervention, n-3 fatty acid, periph-
eral blood mononuclear cells, transcriptome.
Abbreviations: FO, fish oil; HOSO, high oleic sunflower
oil; PBMCs, peripheral blood mononuclear cells;
EPA, eicosapentaenoic acid; DHA, docosahexae-
noic acid; Limma, Linear Models for Microarray
Data; GSEA, gene set enrichment analyses.
Trial registration: ClinicalTrials.gov NCT01034423, Omega-3
Fatty Acids and Health Effects.
ª 2014 The Authors. Journal of Internal Medicine published by John Wiley & Sons Ltd on behalf of The Association for the Publication of the Journal of Internal Medicine. 1
This is an open access article under the terms of the Creative Commons Attribution License,
which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
Original Article
Introduction
It is well documented that consumption of fish and
fish oil (FO) rich in the marine n-3 fatty acids
eicosapentaenoic acid (EPA, 20:5 n-3) and docosa-
hexaenoic acid (DHA, 22:6 n-3) has a positive
health effect in terms of several lifestyle-related
diseases such as cardiovascular disease (CVD)
[1–3]. However, inconsistency of the efficacy of the
marine n-3 fatty acids on CVD outcome was
recently demonstrated in a meta-analysis includ-
ing 20 randomized controlled trials [4]. Studies
exploring the cellular processes specifically modu-
lated by marine n-3 fatty acids in vivo are therefore
needed.
A low chronic state of inflammation can result in
oxidative stress and may therefore promote the
development and progression of lifestyle-related
diseases [5–7]. It has been hypothesized that
inflammation is susceptible to nutritional influ-
ences and, in particular, n-3 fatty acids have been
associated with reduced plasma levels of inflam-
matory markers in epidemiological studies [8–10].
However, the effect seems to be small, and no firm
conclusion can be drawn about the influence of
marine n-3 fatty acids on circulating inflammatory
markers in healthy individuals or those with CVD
[11]. Other approaches including more sensitive
techniques to accurately measure the nutritional
influence of these fatty acids on inflammation and
other nutrient-regulated metabolic processes are
therefore warranted.
The ability of marine n-3 fatty acids to alter gene
expression has been clearly demonstrated, and
this may account for their potential beneficial
health effects. Fatty acids can regulate expression
of genes by acting as ligands for the peroxisomal
proliferator-activated receptors (PPARs) [12]. Acti-
vation of PPARs is known to regulate the expres-
sion of genes involved in lipid metabolism and
inflammation [13]. n-3 fatty acids are also known
to reduce the activation of the transcription factor
nuclear factor kappa B [14] and the Toll-like
receptors [15]. In addition, it has been shown that
signalling pathways upstream of transcription are
modulated by n-3 fatty acids. The G protein-
coupled receptor GPR120 was recently identified
as a receptor/sensor involved in the anti-inflam-
matory effects of n-3 fatty acids [16].
The peripheral blood mononuclear cells (PBMCs)
include monocytes and lymphocytes. PBMCs play a
vital role in inflammation and, hence, may be
important in inflammatory-related diseases. Both
monocytes and lymphocytes are actively involved in
the development of atherosclerotic plaques. Leuko-
cytes respond to changes in the plasma lipid levels
and systemic inflammation by regulating a network
of genes, including those involved in immune
response and lipid and fatty acid metabolism [17].
As increased plasma lipid levels are associated with
an increased risk of atherosclerosis, this may imply
that data obtained from isolated, PBMCs could
reflect the in vivo situation and contribute to biolog-
ical and clinical insights into the human atheroscle-
rotic process. Changes in the expression of genes
related to lipid metabolism and inflammation in
PBMCs have been assessed in dietary intervention
studies both in large-scale microarray analyses and
using single-gene transcripts with quantitative
reverse transcription polymerase chain reaction;
these data were recently reviewed by de Mello et al.
[18]. Furthermore, gene expression studies in
PBMCs seem to reflect changes occurring in meta-
bolically active organs such as the liver, adipose
tissue and skeletal muscle [19–21]. Therefore, in
addition to possibly reflecting changes that occur in
metabolically active organs, PBMCs are easily
accessible and are also directly involved in the
complex inflammation processes that underlie
many lifestyle-related diseases.
We have previously reported that intake of FO
(1.6 g EPA + DHA) for 7 weeks did not change the
levels of serum triglycerides or of markers of
inflammation in healthy subjects [22, 23],
whereas lipidome analyses in the same subjects
showed an increased proportion of plasma trigly-
cerides and phospholipids containing long-chain
polyunsaturated fatty acids (PUFAs) [24]. These
results indicate a remodelling of plasma lipids
towards a more beneficial profile after intake of
FO in healthy subjects. Microarray-based expres-
sion profiling quantifying more than 40 000 tran-
scripts was performed to obtain a more
comprehensive overview of the processes specifi-
cally modulated by EPA and DHA at a molecular
level in PBMCs.
Materials and methods
Subjects
A total of 36 healthy men and women between 18
and 50 years of age who met the eligibility criteria
were included in this study. A detailed description
of the protocol, participant recruitment and
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enrolment, inclusion and exclusion criteria and
compliance is given elsewhere [22]. In brief,
exclusion criteria were fasting levels of total cho-
lesterol >7.5 mmol L1, triglycerides >4 mmol L1,
glucose >6.0 mmol L1 and C-reactive protein
(CRP) >10 mg L1, body mass index (BMI)
≥30 kg m2 and blood pressure (≥160/
100 mmHg). The study was performed at the
Akershus University College, Norway between Sep-
tember and December 2009.
Ethics statement
Written informed consent was obtained from all
participants. The study was approved by the
Regional Committee of Medical Ethics (approval
no. 6.2008.2215) and by the Norwegian Social
Science Data Services (approval no. 21924), and
was conducted in accordance with the Declaration
of Helsinki.
Study design
This study was part of a randomized, controlled,
double-blind, three-arm, parallel-group study,
designed to investigate the health effects of FO
intake [22], in which the transcriptome was analy-
sed as a pre-defined endpoint. Subjects were ran-
domly assigned and stratified by gender into three
groups using equal randomization (1:1:1). Data
from only two of the intervention groups were
analysed in the present study (see Fig. 1). Subjects
were required to take 16 capsules per day contain-
ing a total of 8 g day1 of either FO or high oleic
sunflower oil (HOSO) for 7 weeks and were
instructed to take the capsules with food (during a
minimum of two meals). Subjects in the FO group
received capsules containing a total of 0.7 g day1
EPA + 0.9 g day1 DHA from cod liver oil (Gadidae
sp., EPA/DHAOil 1200, TINESA,Oslo, Norway) and
subjects in the HOSO group received HOSO pur-
chased from AarhusKarlshamn AB (Malm€o, Swe-
den). The fatty acid composition of the oils has been
described elsewhere [22]. The capsule containers
were identical, and the capsules were the same size
and to a large extent similar in colour.
Blood samples were collected for the transcriptome
analyses from subjects at visits at 0, 3 and
7 weeks. Prior to the baseline visit (week 0), a 4-
week washout period was included in which foods
containing marine n-3 fatty acids were excluded
from the diet. During the first 3 weeks of the
intervention period, a fully controlled isocaloric
diet, with all food and beverages provided by
Akershus University College, was consumed. The
composition of the diet and the food items provided
in this study have previously been described [22].
During the last 4 weeks of the intervention, the
subjects returned to their habitual diet. No intake
of fish, fish products, marine n-3-enriched food or
additional dietary supplements was allowed during
the entire study period of 11 weeks. The study was
registered at www.clinicaltrial.gov (identification
number NCT01034423).
Blood sampling
Subjects were asked to refrain from alcohol con-
sumption and vigorous physical activity the day
prior to blood sampling. Venous blood samples
were collected after an overnight fast (≥12 h) at the
same time (2 h). Serum samples were kept at
room temperature for 30 min before centrifugation
(1500 g for 12 min). EDTA tubes with whole blood
were kept at room temperature for a maximum of
48 h before counting the total number of lympho-
cytes and monocytes.
Routine laboratory analyses
Fasting serum concentrations of high-sensitivity
CRP, total-cholesterol, LDL-cholesterol, HDL-cho-
lesterol, triglycerides and glucose as well as lym-
phocyte and monocyte counts were measured by
standard methods in a routine clinical laboratory
(F€urst Medical Laboratory, Oslo, Norway).
PBMCs and RNA isolation
After blood collection, PBMCs were isolated using
the BD Vacutainer Cell Preparation tubes
according to the manufacturer’s instructions (Bec-
ton, Dickinson and Co., Franklin Lakes, NJ, USA).
Pellets were frozen and stored at 80 °C until
further RNA isolation.
Total RNA was isolated from all PBMC samples
using RNeasy Mini Kit (Qiagen, Hilden, Germany)
with lysis buffer with the addition of b-mercapto-
ethanol according to the manufacturer’s instruc-
tions, and stored at 80 °C. RNA quantity and
quality were measured using the ND 1000 Spec-
trophotometer (Saveen Werner AB, Limhamn, Swe-
den) and Agilent Bioanalyser (Agilent Technologies
Inc., Santa Clara, CA, USA), respectively. One
sample had an RNA integrity number (RIN) score
of 3.3; all other samples were above 8 (mean of 9.6).
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Nanodrop analysis did not indicate any contami-
nation in the RNA samples.
Microarray hybridization
Labelled extracts were prepared using Illumina
TotalPrep RNA Amplification Kit (Illumina Inc.,
San Diego, CA, USA) according to the manufac-
turer’s instructions. The labelled extracts were
hybridized to an Illumina HumanHT-12 v4
Expression BeadChip and scanned on an Illumina
HiScan microarray scanner. Illumina GenomeStu-
dio was used to transform bead-level data to
probe-level intensity values and statistics, which
were exported raw (unfiltered and non-normal-
ized) for bioinformatic analysis. After hybridization
and scanning, a manual quality control step was
performed, investigating density plots and hierar-
chical clustering of raw probe densities. All sam-
ples, including the single sample with an RIN
score of <8, displayed good characteristics and
were included in further analyses.
Microarray data analyses
Quantile normalization of the Illumina intensities
was performed. To improve statistical power,
probes without a detectable expression (detection
P-value >0.01) in at least 10% of the samples were
excluded from further analysis. Changes in gene
expression were obtained by calculating log2 ratios
between the intensities at baseline and after
7 weeks, and the two intervention groups were
compared with regard to this ratio. Differentially
expressed genes in each group and between groups
were identified using the Linear Models for Micro-
array Data (Limma) [25] package from Bioconduc-
tor (http://www.bioconductor.org) with R
software. Genes with a nominal P-value <0.05 were
defined as differentially regulated and subjected to
further gene ontology analyses with DAVID soft-
ware version 6.7 (http://david.abcc.ncifcrf.gov).
The list of differentially regulated genes was com-
pared with a reference list (Homo Sapiens), and
biological processes containing more than 10 genes
Assessed for eligibility (n = 83)
Underwent randomization (n = 69)
Excluded (n = 14)
• Not meeting inclusion criteria (n = 8)
• Declined to participate before randomization (n = 6)
Allocated to intervention HOSO group (n = 23)
• Received allocated intervention (n = 20)
• Did not receive allocated intervention (n = 3)
Allocated to intervention FO group (n = 24)
• Received allocated intervention (n = 19)
• Did not receive allocated intervention (n = 5)
Allocated to intervention oxFO group (n = 22)
• Lost to follow-up (n = 0)
• Discontinued intervention (n = 0)
• Excluded (n = 1), low compliance
• Lost to follow-up (n = 0)
• Discontinued intervention (n = 2),
no explanation (n = 1),
abdominal discomfort (n = 1) 
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• Baseline (n = 17)
• Analyzed visit 4 (n = 17)
• Baseline (n = 19) 
• Analyzed visit 4 (n = 19)
Fig. 1 Flow chart showing subjects enrolled, lost during follow-up, and included in the statistical analysis at baseline and
after 7 weeks of fish oil supplementation. FO, fish oil; HOSO, high oleic sunflower oil; oxFO, oxidized fish oil. The oxFO group
was not included in the present study.
M. C. W. Myhrstad et al. Fish oil and transcriptome analyses in PBMCs
4 ª 2014 The Authors. Journal of Internal Medicine published by John Wiley & Sons Ltd on behalf of The Association for the Publication of the Journal of Internal Medicine.
Journal of Internal Medicine
and a False discovery rate (FDR) q-value of <0.1
was considered significantly modulated.
Gene Set Enrichment Analysis (GSEA) (http://
www.broad.mit.edu/gsea/) was applied for the
genes defined as expressed in PBMCs. The gene
sets in the collection of C2 chemical and genetic
perturbations (cgp) and C3 transcription factors
from the Molecular Signatures Database (MSigDB)
were used separately. Permutation (1000) was
performed on phenotypes, and gene sets were
defined as significantly changed for FDR q-values
of <0.25 as recommended for exploratory analyses
by Broad Inst.
The leading edge genes contributing to the signif-
icance of the regulated gene sets were further
analysed for functional and biological pathways
using MetaCore (GeneGo, division of Thomson
Reuters, St. Joseph, MI, USA) for better interpre-
tation of the GSEA result. MetaCore software is a
knowledge database suitable for pathway analysis
of experimental data and gene lists. The Minimum
information about a microarray experiment (MI-
AME) standards [26] were followed in the analysis
and storage of data. The raw data are available
from the Gene Expression Omnibus (GEO) (acces-
sion number GSE48368).
Other statistical analyses
Randomization was carried out by LINK Medical
Research AS (Oslo, Norway) using Microsoft Excel
and its random generator. Differences in baseline
characteristics and number of monocytes and
lymphocytes between the groups at baseline or
after 7 weeks were compared by Student’s t-test or
Mann–Whitney U test when normally and not
normally distributed, respectively, using SPSS for
windows (SPSS, version 19.0, IBM Corp, Armonk,
NY, USA). The significance level was set to 5% (two-
sided).
Results
Subject characteristics
A total of 36 normal-weight healthy subjects (26
women and 10 men) completed the study. Subjects
were young and middle-aged adults
(28.0  8.1 years), with serum lipids within the
normal range as shown in Table 1. No differences
in age, BMI, serum lipids, glucose or total numbers
of monocytes and lymphocytes were observed
between the FO group (n = 17) and the HOSO
group (n = 19) at baseline (Table 1) or after
7 weeks of intervention (data not shown). The
plasma level of n-3 fatty acids was increased in
subjects consuming FO compared to the control
group, as previously described [22].
Gene expression profiling in PBMCs
Microarray hybridization was performed on RNA
from PBMCs collected at baseline and after
7 weeks of supplementation from all subjects in
both groups. All the microarrays fulfilled the
employed quality criteria (see Materials and meth-
ods). From the 48 000 probes presented on the
Table 1 Baseline characteristics
HOSO (n = 19) FO (n = 17) P-value
Male/female 5/14 5/12
Age (years) 28.6  9.1 27.2  6.9 0.98
TC (mmol L1) 4.9  0.8 4.6  0.8 0.27
LDL-C (mmol L1) 2.7  0.6 2.5  0.8 0.41
HDL-C (mmol L1) 1.5  0.4 1.5  0.3 0.86
TG (mmol L1) 1.0  0.5 0.9  0.6 0.43
Glucose (mmol L1) 4.8  0.5 4.6  0.3 0.21
BMI (kg m2) 23.5  3.1 22.1  2.5 0.16
Monocytes (9109 L1) 0.53  0.17 0.46  0.13 0.20
Lymphocytes (9109 L1) 2.17  0.50 2.11  0.57 0.77
TC, total cholesterol; LDL-C, LDL-cholesterol; HDL-C, HDL-cholesterol; TG, triglycerides; BMI, body mass index.
Data are given as mean  SD. Differences between the groups were calculated using t-test when normally distributed and
Mann–Whitney U test when not normally distributed (age, triglycerides).
M. C. W. Myhrstad et al. Fish oil and transcriptome analyses in PBMCs
ª 2014 The Authors. Journal of Internal Medicine published by John Wiley & Sons Ltd on behalf of The Association for the Publication of the Journal of Internal Medicine. 5
Journal of Internal Medicine
HumanHT-12 v4 microarray, 21 236 were defined
as expressed in PBMCs.
Differences in gene expression between the two
groups were determined by a moderated t-test
(Limma), by comparing the relative change from
baseline to 7 weeks of intervention among the
21 236 expressed genes. Overall, 470 genes were
found to be differentially expressed between the
two intervention groups (P < 0.05). However, no
genes were significantly differentially expressed
(FDR q-value of <0.1) between the two groups after
adjusting for multiple testing (Table S1). The mag-
nitude of the gene expression changes in the FO
group ranged between +58% and 23% compared
to the control group. Gene transcripts differentially
expressed and changed by more than 20% in the
FO group compared with the HOSO group are
included Table 2.
To identify differences across the two intervention
groups, we analysed functional relationships
among the 470 differentially expressed genes
obtained with Limma using the pathway tool
DAVID. This tool tests whether any biological
processes are significantly enriched among the list
of differentially regulated gene transcripts com-
pared to a reference list (Homo Sapiens). Using the
list of differentially expressed genes, 236 upregu-
lated and 234 downregulated gene transcripts were
identified compared to the HOSO group. The lists of
upregulated and downregulated gene transcripts
were analysed for enriched biological processes
separately. Several biological processes were signif-
icantly enriched among the upregulated gene tran-
scripts. These processes are involved in cell cycle
and DNA packing and chromosome organization
(see Table 3). No processes were significantly asso-
ciated with the genes transcripts that were down-
regulated by FO compared to HOSO.
A moderated t-test (using Limma) identified 11
significantly changed gene transcripts in the FO
group among the 21 236 expressed genes (FDR
q-value of <0.1) after 7 weeks. No gene transcripts
were found to be significantly changed from base-
line after intake of HOSO. Three small nucleolar
RNAs (SNORD13, SNORA12 and SNORD12C), two
mRNA transcripts coding for VNN2 and the mRNA
transcript for CD55 were downregulated after
intake of FO for 7 weeks (Table S2).
GSEA
Gene Set Enrichment Analysis was used to test
whether groups of genes involved in the same
biological process or pathway, or regulated by the
same transcription factor, were changed after
intake of FO compared with the control group
among the 21 236 defined expressed genes. The
relative changes from baseline after 7 weeks of
intervention were compared in the two groups.
Overall, 162 gene sets were significantly enriched
(FDR q-value of <0.25; 72 with FDR q-value of
<0.15) in the FO group compared with the HOSO
group in the C2 cgp collection (MSigDB). These
gene sets included several overlapping genes.
Leading edge genes (1460 non-overlapping genes
shown in Table S3) contributing to the significance
of the regulated gene sets were further analysed for
functional and biological pathways using MetaCore
for better interpretation of the GSEA result. The
results were ranked by their P-value and annotated
onto the developed pathway maps. It is interesting
Table 2 Gene transcripts differentially expressed and changed by more than 20% in the FO group compared with the HOSO
group after 7 weeks of intervention (identified using Limma analyses; P > 0.05)
Gene Symbole Probe_id FO vs. HOSO P-value FO vs. HOSO FC
LOC100130100 ILMN_1739508 0.028 1.59
LOC100130100 ILMN_1699214 0.024 1.59
NA ILMN_1680274 0.017 1.55
NA ILMN_3240375 0.028 1.54
IGLL1 ILMN_2393765 0.015 1.50
IL32 ILMN_2368530 0.010 1.25
IRF4 ILMN_1754507 0.013 1.22
CCL3L3 ILMN_2105573 0.002 1.20
SIGLEC14 ILMN_3243061 0.045 0.77
NA, not assigned; FC, fold change; FO, fish oil; HOSO, high oleic sunflower oil.
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that several pathways were significantly regulated
among the leading edge genes. The top 10 pathway
maps (FDR q-value of <0.05) were related to cell
cycle, apoptosis, immune response, protein folding
and maturation, and DNA damage (Table 4). Meta-
core pathway maps of the Anaphase-promoting
complex (APC) regulation of cell cycle and endo-
plasmic reticulum (ER) stress response are shown
in Figs 2 and 3, respectively.
Finally, to explore the regulatory mechanisms
underlying the change in gene regulation we per-
formed a GSEA analysis to test whether groups of
genes with common cis-motifs were differentially
regulated among the defined expressed genes.
Forty-nine gene sets were significantly upregulated
after intake of FO, compared with HOSO, using the
C3 collection (MSigDB) (Table S4). These included
genes regulated by a common cis-acting element
with binding sites for 35 known transcription
factors such as E2F transcription factor, nuclear
respiratory factor 1 (NRF1), tumour protein 53
(TP53), SP1 transcription factor (SP1), activating
transcription factor and 2 (ATF4 and ATF2), Fork-
headboxO4 (FOXO4),macrophagemigration inhib-
itory factor (MIF), signal transducer and activator of
transcription 1 (STAT1), hypoxia inducible factor 1,
alpha subunit (HIF1A), sterol regulatory element
binding transcription factor 1 (SREBP1) andhepatic
nuclear factor 4 alpha (HNF4A) (Table 5).
Transcriptome analyses were also performed after
3 weeks of intervention. The gene transcripts iden-
tified as differentially expressed according to
Limma analyses (P < 0.05) were involved in the
cell cycle, chromosome organization, response to
oxidative stress, translation and regulation of
apoptosis (data not shown). Using GSEA analyses,
no gene sets were identified as differentially
expressed between the two groups after 3 weeks.
Discussion
We have investigated the transcriptome profile of
PBMCs after intake of FO in a randomized con-
trolled dietary intervention trial with healthy sub-
jects. Intake of FO containing 1.6 g day1 DHA and
EPA for 7 weeks modulated gene transcripts
related to biological processes and pathways such
as cell cycle, ER stress and apoptosis compared
with control (intake of HOSO). These processes and
pathways were identified using an exploratory
approach with several data analysis strategies. A
similar transcriptome profile was observed after
Table 3 Enriched biological processes in the FO group compared to the HOSO group after 7 weeks of intervention among the
upregulated genes obtained with Limma analysis (P < 0.05)
Biological process Genes Fold enrichment P-value FDR
GO:0022402/cell
cycle process
KIFC1, MND1, UBE2C, DDIT3,
CDK2, CCNE1, MLL5, TUBB,
BUB1, MAPRE2, H2AFX, GFI1,
HELLS, UBA52
2.63 0.00 0.04
GO:0006323/DNA
packaging
H2AFV, H2AFX, NAP1L3, NCAPH2,
ASF1B, HELLS
5.62 0.00 0.07
GO:0022403/cell
cycle phase
CCNE1, KIFC1, TUBB, BUB1, MND1,
H2AFX, MAPRE2, GFI1, UBE2C,
HELLS, CDK2
2.83 0.01 0.08
GO:0051276/
chromosome
organization
KIFC1, MLL5, H2AFV, PRMT7, INO80,
H2AFX, NAP1L3, IRF4, NCAPH2,
TERF2IP, ASF1B, HELLS
2.64 0.01 0.09
GO:0007049/cell cycle KIFC1, JAG2, MND1, UBE2C, MCM3,
DDIT3, CDK2, CCNE1, MLL5, TUBB,
BUB1, MAPRE2, H2AFX, GFI1,
UBA52, HELLS
2.19 0.01 0.09
GO, Gene ontology term; FDR, false discovery rate.
Enriched biological processes were identified using DAVID (FDR q-value of <0.1).
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3 weeks of intervention (results not shown); how-
ever, the effect was more prominent at the end of
the 7-week intervention.
Gene transcripts involved in several phases of the
cell cycle were identified as significantly modulated
after intake of FO compared with control (intake of
HOSO). Modulation of cell cycle gene transcripts
was characterized by increased expression of cyc-
lins and cyclin-dependent kinases as shown in
Fig. 2 and Table 3. Cyclins and cyclin-dependent
kinases are involved in and control the transition
through G1, S, G2 and the M phase of cell cycling
[27]. Our results are in accordance with previously
published data demonstrating upregulation of sev-
eral key gene transcripts (CDK2, CDK4, CCND2,
PCNA, MCM6) involved in cell cycle and DNA
synthesis in PBMCs after intake of FO (1.8 g day1
EPA + DHA) in elderly subjects for 26 weeks [28].
In addition, pathways related to the cell cycle were
upregulated by FO and slightly downregulated
after intake of HOSO [28, 29]. Taken together,
intake of FO may increase key regulatory genes
involved in cell cycle progression at a transcrip-
tional level in PBMCs. n-3 fatty acids have previ-
ously been shown to inhibit cell proliferation and
cell growth of cancer cell lines in vitro [30–32]. Key
cell cycle regulators and target proteins of cancer
therapy were recently found to be downregulated
by DHA in a human colon cancer cell line in vitro
[31, 33]. The discrepancies observed between the
effect of n-3 fatty acids on cancer cells in vitro and
in studies of PBMCs from healthy subjects may be
related to the fact that cancer cells have lost
normal cell functions and are characterized by
mutations in genes controlling cell cycle, repair
functions and/or cell death.
We did not observe any change in the total number
of monocytes or lymphocytes after intake of FO,
indicating that the potential activation of cell cycle
progression is accompanied by induction of cell
death. This is supported by the observation that
gene transcripts involved in the ER stress response
and apoptosis were upregulated after intake of FO
compared with control (HOSO). ER stress is
induced under conditions of cellular stress and
activates the unfolded protein response (UPR) to
maintain cellular homeostasis [34], and sustained
ER stress may lead to apoptosis [35]. ER stress is
associated with several diseases such as cancer,
neurodegenerative disorders and atherosclerosis
[36–38]. In this study, we found that genes with the
common regulatory motifs for ATF4 and MIF1 were
upregulated after intake of FO. ATF4 is a tran-
scription factor involved in ER stress and the UPR
response [34], and MIF1 was recently linked to the
degradation of proteins during the UPR response
[39]. In agreement with our finding, the gene
transcript of MIF1 in PBMCs was found to be
significantly increased after intake of FO in the
elderly [28]. Recent observations in cancer cell
lines have shown that DHA may induce ER stress
and increase ATF4 both at the protein and tran-
scriptional levels [31]. How n-3 fatty acids induce
ER stress is not known. However, the n-3 fatty
acids EPA and DHA are susceptible to oxidation
and may form lipid peroxidation products that
could influence the cellular redox state, lead to
oxidative stress and thereby induce ER stress. It is
interesting that a higher expression level of auto-
phagy-related genes was recently identified in
Table 4 Leading edge genes identified with the C2 cgp
collection (see Table S4) are visualized using Metacore
Pathway maps Ratio
Cell cycle. The metaphase checkpoint 36/21
Protein folding and maturation.
POMC processing
30/18
Immune response. IL-2 activation and
signalling pathway
49/22
Cell cycle. Role of APC in cell cycle
regulation
32/17
Immune response. CD16 signalling
in NK cells
69/24
Cell cycle. Start of DNA replication in
early S phase
32/16
Cell cycle. Spindle assembly and
chromosome separation
33/15
Apoptosis and survival. Endoplasmic
reticulum stress response pathway
53/19
DNA damage. ATM/ATR regulation
of G1/S checkpoint
32/14
Apoptosis and survival. FAS signalling
cascades
44/16
FDR, false discovery rate; ATM, ataxia-telangiectasia
mutated; ATR, ATM- and rad3-related; APC, anaphase-
promoting complex; NK, natural killer; FAS, tumour
necrosis factor receptor superfamily member 6.
The top 10 pathways are shown (FDR q-value of <0.05).
Ratio indicates the number of genes represented in the
pathway maps/number of genes identified in the leading
edge analyses.
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individuals with a high plasma ratio of n-3/n-6
compared to those with lower ratios [40].
Autophagy is a prosurvival mechanism that may
have a role in restoring cellular homeostasis after
oxidative and ER stress [41] and is also closely
linked to lipid metabolism [42].
Increased expression of genes that share common
regulatory elements for the transcription factors
E2F, TP53, STAT1, FOXO4 and SP1 further high-
lights the fact that intake of FO modulates cell
cycle and apoptosis. In accordance with our find-
ings showing increased expression of TP53 target
genes, the mRNA transcript of TP53 were found to
be elevated by Bouwens et al. [28] following intake
of FO in PBMCs.
The expression of target genes with the regulatory
motifs for NRF1was also increased after FO sup-
plementation when compared with the HOSO
group. NRF1 target genes are involved in mito-
chondrial function and biogenesis. Impairment
of mitochondrial functions is associated with
age-related disorders such as type 2 diabetes
and Alzheimer’s disease [43, 44], and increased
mitochondrial number has been associated with
the life-extending effects of exercise and energy
restriction in rats [45, 46]. Similar to our findings,
intake of a diet rich in antioxidants and PUFAs
has been shown to regulate NRF2 target genes in
blood cells of healthy subjects [47]. We have also
identified increased expression of genes with the
regulatory motif for HIF1A after intake of FO.
HIF1A controls the hypoxic response occurring at
low oxygen tension and HIF1A target genes are
involved in stress and defence responses [48]. Of
note, Bøhn et al. [47] also found that HIF1A target
genes were induced at a transcriptional level in
Fig. 2 Metacore analysis of leading edge genes. The pathwaymap showing the role of APC in cell cycle regulation, identified
with theMetacore (GeneGo) pathway tool, among the leadingedgegenes fromgeneset enrichment analysesusing the geneset
collection C2 cgp. The leading edge genes were found to be upregulated after intake of fish oil (FO) compared with high oleic
sunflower oil (HOSO). The experimental data are shown on the maps as ‘thermometer-like’ figures. Upward thermometers
(red) indicate upregulated gene transcripts in the FO group and downward thermometers (blue) indicate downregulated
expression levels of the genes in the HOSO group. Further explanations are provided at http://pathwaymaps.com/pdf/
MC_legend.pdf. cgp, chemical and genetic perturbations. APC, anaphase-promoting complex.
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blood cells. Taken together, these findings suggest
that changes in gene transcripts towards an
optimization of defence and stress processes may
represent a potential way to maintain cellular
functions upon exposure of redox active compo-
nents in food.
Changes in the whole-genome expression profile in
PBMCs or blood cells after intake of FO or n-3
supplements in healthy subjects, the elderly or
patients with dyslipidaemia or Alzheimer’s disease
have been reported in several studies, and the
changes are associated with lipid metabolism,
antioxidant defence and inflammation [28, 49–
53]. However, the biological significance of these
previous studies should be determinedwith caution
as either no control was included [52], the mRNA
samples from the subjects were pooled [49–51]
or the within-group changes in the intervention
group and the control group were reported sepa-
rately [28, 53].
The present study has several strengths including
the double-blind, randomized, controlled study
design and the use of several data analysis strat-
egies in which the effect of FO intake was compared
with that of HOSO. Among the limitations are the
relatively short intervention period and the small
number of subjects included. The genes identified
as responsive to intake of FO were not significantly
differentially expressed following adjustment for
multiple testing. This is in agreement with the
Fig. 3 Metacore analysis of leading edge genes. The pathway map: apoptosis and endoplasmic reticulum stress, identified
with theMetacore (GeneGo) pathway tool among the leading edge genes from gene set enrichment analyses using the gene set
collection C2 cgp. The leading edge genes were found to be upregulated after intake of fish oil (FO) compared with high oleic
sunflower oil (HOSO). The experimental dataare shownon themapsas ‘thermometer-like’ figures.Upward thermometers (red)
indicate upregulated gene transcripts in the FO group and downward thermometers (blue) indicate the downregulated
expression levels of the genes in the HOSO group. Further explanations are provided at http://pathwaymaps.com/pdf/
MC_legend.pdf.
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Table 5 Gene set enrichment analyses. Enriched gene sets from the C3 transcription factor targets collection (MSigDB) in the
FO group compared to the HOSO group
Gene set NES P-value Transcription factor
V$SP1_Q2_01 1.63 0.00 SP1 transcription factor
V$E2F_Q6_01 1.61 0.01 E2F: TFDP1
V$HNF4_01 1.59 0.00 HNF4A, NR2A1: hepatic nuclear factor 4 alpha
V$PAX8_01 1.57 0.03 PAX 8 (paired box 8)
V$TBP_01 1.57 0.01 TBP (TATA box binding protein)
V$CREBP1_Q2 1.56 0.00 ATF2 (activating transcription factor 2)
V$PAX5_01 1.55 0.01 PAX5 (paired box 5)
V$TATA_C 1.54 0.01 TAF8: TBP-associated factor
V$LMO2COM_01 1.54 0.00 LMO2: LIM domain only 2 (rhombotin-like 1)
V$NRF1_Q6 1.51 0.00 NRF1 (nuclear respiratory factor 1)
V$SP1_01 1.50 0.02 SP1 transcription factor
V$FOXO4_01 1.49 0.02 FOXO4 (forkhead box O4)
V$ATF4_Q2 1.49 0.02 ATF4 (activating transcription factor 4)
V$COUP_01 1.49 0.02 NR2F1
V$AP4_Q6_01 1.48 0.01 AP4 (AP4 zinc finger protein)
V$MIF1_01 1.48 0.04 MIF: macrophage migration inhibitory factor
(glycosylation-inhibiting factor)
CTAWWWATA_V$RSRFC4_Q2 1.47 0.01 MEF2A (myocyte enhancer factor 2A)
V$GRE_C 1.47 0.01 NR3C1: nuclear receptor subfamily 3, group C, member 1
(glucocorticoid receptor)
V$SREBP_Q3 1.46 0.01 SREBF1 (sterol regulatory element binding transcription factor 1)
V$STAT1_03 1.45 0.02 STAT1 (signal transducer and activator of transcription 1)
V$HIF1_Q3 1.45 0.01 HIF1a (hypoxia-inducible factor 1, alpha subunit)
V$AP4_Q5 1.44 0.02 AP4 (AP4 zinc finger protein)
V$RP58_01 1.44 0.02 ZBTB18 (zinc finger and BTB domain containing 18)
V$ZIC1_01 1.43 0.03 ZIC1 (Zic family member 1)
V$COREBINDINGFACTOR_Q6 1.43 0.02 CBFA2T2 (core-binding factor, runt domain, alpha subunit 2;
translocated to, 2)
V$AP1_Q6_01 1.43 0.03 JUN (Jun oncogene)
V$CP2_01 1.42 0.03 TFCP2 (transcription factor CP2)
V$SREBP1_Q6 1.42 0.04 SREBF1 (sterol regulatory element binding transcription factor 1)
V$EVI1_02 1.42 0.03 EVI1 (ecotropic viral integration site)
V$TAL1BETAITF2_01 1.42 0.01 TAL1 (T-cell acute lymphocytic leukaemia 1)
V$P53_02 1.42 0.04 TP53 (tumour protein 53)
V$STAT_Q6 1.40 0.04 STAT1 (signal transducer and activator of transcription 1)
V$FOXJ2_01 1.40 0.03 FOXJ2 (forkhead box J2)
V$MYCMAX_B 1.39 0.02 MAX (MYC associated factor X)
V$ZIC2_01 1.39 0.03 ZIC2 (zic family member 2)
NES, normalized enrichment score; FO, fish oil; HOSO, high oleic sunflower oil; MSigDB, Molecular Signatures Database.
Gene sets with cis-acting binding sites for known transcription factors are presented. Gene sets with an FDR q-value of
<0.25 were considered significantly enriched in the FO group.
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findings of other nutrigenomic studies and is
probably related to the small effect of nutrients
on gene expression, both with regard to the
proportion of gene transcripts changed and to the
induction of the changes in gene expression con-
cordance with large inter-individual variations
[29, 47]. The magnitude of the gene expression
changes observed ranged between +58% and 23%
compared with the control group and is in line with
the findings of other dietary transcriptome studies
[28, 53]. However, these moderate changes over
time may still have an impact on health and
lifestyle-related disease [54]. In the current explor-
atory study, we therefore focused on regulated
biological processes and groups of genes (gene sets)
rather than single genes to identify the effect of FO
on the transcriptome profile. The processes and
pathways identified were upregulated in the FO
group compared with the HOSO group. Whether
these effects are specific effects of n-3 fatty acids
rather than other long chain PUFAs such as n-6
PUFAs remains to be elucidated.
To our knowledge, this is the first study to identify
changes in gene expression after intake of FO
compared with a control group in a dietary
intervention study. Using an exploratory approach,
we have identified enriched biological processes
and pathways related to cell cycle, ER stress
response and apoptosis after intake of FO. These
processes and pathways are involved in normal cell
function and may ultimately influence whole body
health.
Funding
This study was supported by the Research Council
of Norway (project no. 184813/110), Oslo and
Akershus University College of Applied Sci-
ences, Norway, the University of Oslo, Norway
and the Throne Holst Foundation for Nutrition
Research.
Authors’ contributions
MCWM, SMU, IO, GIB, KWB and KBH were
responsible for study concept and design; MCWM,
SMU, IO, ER and KBH conducted the research;
MCWM, SMU, C-CG, IO, MH, ER, MT and KBH
performed data analysis and interpretation;
MCWM, SMU, IO and KBH wrote the manuscript;
and all authors approved the final version to be
published.
Conflict of interests statement
KWB is a clinical nutritionist/project manager at
the TINE SA R&D Center, Norway, with no financial
interest. None of the other authors has any conflict
of interests.
Acknowledgements
The microarray analyses were performed by the
Genomics Core Facility, Norwegian University of
Science and Technology and NMC – a national
technology platform supported by the functional
genomics programme (FUGE) of the Research
Council of Norway.
References
1 Hu FB, Bronner L, Willett WC et al. Fish and omega-3 fatty
acid intake and risk of coronary heart disease in women.
JAMA 2002; 287: 1815–21.
2 He K, Song Y, Daviglus ML et al. Accumulated evidence on fish
consumption and coronary heart disease mortality: a
meta-analysis of cohort studies.Circulation2004;109:2705–11.
3 GISSI-Prevenzione Investigators. Dietary supplementation
with n-3 polyunsaturated fatty acids and vitamin E after
myocardial infarction: results of the GISSI-Prevenzione trial.
Gruppo Italiano per lo Studio della Sopravvivenza nell’Infarto
miocardico. Lancet 1999; 354: 447–55.
4 Rizos EC, Ntzani EE, Bika E, Kostapanos MS, Elisaf MS.
Association between omega-3 fatty acid supplementation and
risk of major cardiovascular disease events: a systematic
review and meta-analysis. JAMA 2012; 308: 1024–33.
5 Packard RR, Libby P. Inflammation in atherosclerosis: from
vascular biology to biomarker discovery and risk prediction.
Clin Chem 2008; 54: 24–38.
6 Bryan S, Baregzay B, Spicer D, Singal PK, Khaper N.
Redox-inflammatory synergy in the metabolic syndrome.
Can J Physiol Pharmacol 2013; 91: 22–30.
7 Federico A, Morgillo F, Tuccillo C, Ciardiello F, Loguercio C.
Chronic inflammation and oxidative stress in human carci-
nogenesis. Int J Cancer 2007; 121: 2381–6.
8 Calder PC. n-3 polyunsaturated fatty acids, inflammation, and
inflammatory diseases.Am JClin Nutr 2006; 83: 1505S–19S.
9 Lopez-Garcia E, Schulze MB, Manson JE et al. Consumption
of (n-3) fatty acids is related to plasma biomarkers of
inflammation and endothelial activation in women. J Nutr
2004; 134: 1806–11.
10 Madsen T, Skou HA, Hansen VE et al. C-reactive protein,
dietary n-3 fatty acids, and the extent of coronary artery
disease. Am J Cardiol 2001; 88: 1139–42.
11 Myhrstad MC, Retterstol K, Telle-Hansen VH et al. Effect of
marine n-3 fatty acids on circulating inflammatory markers in
healthy subjects and subjects with cardiovascular risk fac-
tors. Inflamm Res 2011; 60: 309–19.
12 Kliewer SA, Sundseth SS, Jones SA et al. Fatty acids and
eicosanoids regulate gene expression through direct
M. C. W. Myhrstad et al. Fish oil and transcriptome analyses in PBMCs
12 ª 2014 The Authors. Journal of Internal Medicine published by John Wiley & Sons Ltd on behalf of The Association for the Publication of the Journal of Internal Medicine.
Journal of Internal Medicine
interactions with peroxisome proliferator-activated receptors
alpha and gamma. Proc Natl Acad Sci U SA 1997;94: 4318–23.
13 Tontonoz P, Spiegelman BM. Fat and beyond: the diverse
biology of PPARgamma. Annu Rev Biochem 2008; 77: 289–
312.
14 Castrillo A, Tontonoz P. Nuclear receptors in macrophage
biology: at the crossroads of lipid metabolism and inflamma-
tion. Annu Rev Cell Dev Biol 2004; 20: 455–80.
15 Lee JY, Plakidas A, Lee WH et al. Differential modulation of
Toll-like receptors by fatty acids: preferential inhibition by n-3
polyunsaturated fatty acids. J Lipid Res 2003; 44: 479–86.
16 Oh DY, Talukdar S, Bae EJ et al. GPR120 is an omega-3 fatty
acid receptor mediating potent anti-inflammatory and insu-
lin-sensitizing effects. Cell 2010; 142: 687–98.
17 Ma J, Dempsey AA, Stamatiou D, Marshall KW, Liew CC.
Identifying leukocyte gene expression patterns associated
with plasma lipid levels in human subjects. Atherosclerosis
2007; 191: 63–72.
18 de Mello VD, Kolehmanien M, Schwab U, Pulkkinen L,
Uusitupa M. Gene expression of peripheral blood mononu-
clear cells as a tool in dietary intervention studies: what do we
know so far? Mol Nutr Food Res 2012; 56: 1160–72.
19 Bouwens M, Afman LA, Muller M. Fasting induces changes in
peripheral blood mononuclear cell gene expression profiles
related to increases in fatty acid beta-oxidation: functional
role of peroxisome proliferator activated receptor alpha in
human peripheral blood mononuclear cells. Am J Clin Nutr
2007; 86: 1515–23.
20 Bakker GC, van Erk MJ, Pellis L et al. An antiinflammatory
dietary mix modulates inflammation and oxidative and met-
abolic stress in overweight men: a nutrigenomics approach.
Am J Clin Nutr 2010; 91: 1044–59.
21 Rudkowska I, Raymond C, Ponton A et al. Validation of the
use of peripheral blood mononuclear cells as surrogate model
for skeletal muscle tissue in nutrigenomic studies. OMICS
2011; 15: 1–7.
22 Ottestad I, Vogt G, Retterstol K et al. Oxidised fish oil does not
influence established markers of oxidative stress in healthy
human subjects: a randomised controlled trial. Br J Nutr
2011; 108: 315–26.
23 Ottestad I, Retterstol K, Myhrstad MC et al. Intake of oxidised
fish oil does not affect circulating levels of oxidised LDL or
inflammatory markers in healthy subjects. Nutr Metab Car-
diovasc Dis 2013; 23: e3–4.
24 Ottestad I, Hassani S, Borge GI et al. Fish oil supplementa-
tion alters the plasma lipidomic profile and increases long--
chain PUFAs of phospholipids and triglycerides in healthy
subjects. PLoS One 2012; 7: e42550.
25 Smyth GK. Linear models and empirical bayes methods for
assessing differential expression in microarray experiments.
Stat Appl Genet Mol Biol 2004; 3: Article3.
26 Brazma A, Hingamp P, Quackenbush J et al. Minimum
information about a microarray experiment (MIAME)-toward
standards for microarray data. Nat Genet 2001; 29: 365–
71.
27 Vermeulen K, Van Bockstaele DR, Berneman ZN. The cell
cycle: a review of regulation, deregulation and therapeutic
targets in cancer. Cell Prolif 2003; 36: 131–49.
28 Bouwens M, van de Rest O, Dellschaft N et al. Fish-oil
supplementation induces antiinflammatory gene expression
profiles in human blood mononuclear cells. Am J Clin Nutr
2009; 90: 415–24.
29 Afman LA, Muller M. Human nutrigenomics of gene regula-
tion by dietary fatty acids. Prog Lipid Res 2012; 51: 63–70.
30 Finstad HS, Myhrstad MC, Heimli H et al. Multiplication and
death-type of leukemia cell lines exposed to very long-chain
polyunsaturated fatty acids. Leukemia 1998; 12: 921–9.
31 Jakobsen CH, Storvold GL, Bremseth H et al. DHA induces
ER stress and growth arrest in human colon cancer cells:
associations with cholesterol and calcium homeostasis.
J Lipid Res 2008; 49: 2089–100.
32 Danbara N, Yuri T, Tsujita-Kyutoku M et al. Conjugated
docosahexaenoic acid is a potent inducer of cell cycle arrest
and apoptosis and inhibits growth of colo 201 human colon
cancer cells. Nutr Cancer 2004; 50: 71–9.
33 Slagsvold JE, Pettersen CH, Storvold GL, Follestad T, Krokan
HE, Schonberg SA. DHA alters expression of target proteins of
cancer therapy in chemotherapy resistant SW620 colon
cancer cells. Nutr Cancer 2010; 62: 611–21.
34 Schroder M, Kaufman RJ. ER stress and the unfolded protein
response. Mutat Res 2005; 569: 29–63.
35 Benbrook DM, Long A. Integration of autophagy, proteasomal
degradation, unfolded protein response and apoptosis. Exp
Oncol 2012; 34: 286–97.
36 Brown MK, Naidoo N. The endoplasmic reticulum stress
response in aging and age-related diseases. Front Physiol
2012; 3: 263.
37 Minamino T, Kitakaze M. ER stress in cardiovascular disease.
J Mol Cell Cardiol 2010; 48: 1105–10.
38 Zhang K, Kaufman RJ. The unfolded protein response: a
stress signaling pathway critical for health and disease.
Neurology 2006; 66: S102–9.
39 van Laar T, Schouten T, Hoogervorst E, van Eck M, van der Eb
AJ, Terleth C. The novel MMS-inducible gene Mif1/KIAA0025
is a target of the unfolded protein response pathway. FEBS
Lett 2000; 469: 123–31.
40 Olsen KS, Fenton C, Froyland L, Waaseth M, Paulssen RH,
Lund E. Plasma Fatty Acid ratios affect blood gene expression
profiles – a cross-sectional study of the norwegian women and
cancer post-genome cohort. PLoS One 2013; 8: e67270.
41 Yang Z, Klionsky DJ. Mammalian autophagy: core molecular
machinery and signaling regulation. Curr Opin Cell Biol 2010;
22: 124–31.
42 Singh R, Kaushik S, Wang Y et al. Autophagy regulates lipid
metabolism. Nature 2009; 458: 1131–5.
43 Huang JH, Hood DA. Age-associated mitochondrial dysfunc-
tion in skeletal muscle: contributing factors and suggestions
for long-term interventions. IUBMB Life 2009; 61: 201–14.
44 Gibson GE, Karuppagounder SS, Shi Q. Oxidant-induced
changes in mitochondria and calcium dynamics in the
pathophysiology of Alzheimer’s disease. Ann N Y Acad Sci
2008; 1147: 221–32.
45 Lee CK, Klopp RG, Weindruch R, Prolla TA. Gene expression
profile of aging and its retardation by caloric restriction.
Science 1999; 285: 1390–3.
46 Nisoli E, Tonello C, Cardile A et al. Calorie restriction
promotes mitochondrial biogenesis by inducing the expres-
sion of eNOS. Science 2005; 310: 314–7.
47 Bøhn SK, Myhrstad MC, Thoresen M et al. Blood cell gene
expression associated with cellular stress defense is modu-
lated by antioxidant-rich food in a randomised controlled
clinical trial of male smokers. BMC Med 2010; 8: 54.
48 Semenza GL. Targeting HIF-1 for cancer therapy. Nat Rev
Cancer 2003; 3: 721–32.
M. C. W. Myhrstad et al. Fish oil and transcriptome analyses in PBMCs
ª 2014 The Authors. Journal of Internal Medicine published by John Wiley & Sons Ltd on behalf of The Association for the Publication of the Journal of Internal Medicine. 13
Journal of Internal Medicine
49 Schmidt S, Stahl F, Mutz KO, Scheper T, Hahn A, Schuchardt
JP. Different gene expression profiles in normo- and dyslip-
idemic men after fish oil supplementation: results from
a randomized controlled trial. Lipids Health Dis 2012; 11:
105.
50 Schmidt S, Stahl F, Mutz KO, Scheper T, Hahn A, Schuchardt
JP. Transcriptome-based identification of antioxidative gene
expression after fish oil supplementation in normo- and
dyslipidemic men. Nutr Metab 2012; 9: 45.
51 Schmidt S, Willers J, Stahl F et al. Regulation of lipid
metabolism-related gene expression in whole blood cells of
normo- and dyslipidemic men after fish oil supplementation.
Lipids Health Dis 2012; 11: 172.
52 Rudkowska I, Paradis AM, Thifault E et al.Transcriptomic and
metabolomic signatures of an n-3 polyunsaturated fatty acids
supplementation in a normolipidemic/normocholesterolemic
Caucasian population. J Nutr Biochem 2013; 24: 54–61.
53 Vedin I, Cederholm T, Freund-Levi Y et al. Effects of DHA-rich
n-3 fatty acidsupplementation on gene expression in blood
mononuclear leukocytes: the OmegAD study. PLoS One 2012;
7: e35425.
54 Afman L, Muller M. Nutrigenomics: from molecular nutrition
to prevention of disease. J Am Diet Assoc 2006; 106: 569–76.
Correspondence: Mari C. W. Myhrstad, Department of Health,
Nutrition and Management, Faculty of Health Sciences, Oslo and
Akershus University College of Applied Sciences, PO Box 4, St
Olavs plass, 0130 Oslo, Norway
(fax: +47 64849001; e-mail: mari.myhrstad@hioa.no).
Supporting Information
Additional Supporting Information may be found in
the online version of this article:
Table S1. Genes differentially expressed between
the two goups (P < 0.05).
Table S2. Significantly regulated gene transcripts
(FDR < 10%) after intake of fish oil for 7 weeks
compared to baseline. The fold change from base-
line is presented. Gene transcripts were identified
with paired moderate t-test (Limma). The corre-
sponding values in the HOSO group are presented.
Table S3. Leading edge genes contributing to the
significance of the enriched gene sets in the FO
group.
Table S4. GSEA analyses. Enriched gene sets in
the FO group compared with the HOSO group from
the C3 transcription factor collection (MSigDB).
Gene sets with FDR q-value <0.25 were consider
significantly enriched in the FO group.
M. C. W. Myhrstad et al. Fish oil and transcriptome analyses in PBMCs
14 ª 2014 The Authors. Journal of Internal Medicine published by John Wiley & Sons Ltd on behalf of The Association for the Publication of the Journal of Internal Medicine.
Journal of Internal Medicine
